Colorado State University’s Translational Medicine Institute is a high-tech hub, bringing together scholars, creators, and entrepreneurs to work in collaborative spaces where innovation thrives. The Institute’s goal is to discover and deliver solutions that utilize the body’s healing capacity and improves the lives of animals and the humans who care for them.
news and updates view all
AJVR: NITRO-charged: Colorado State veterinary scientists partner on impactful osteoarthritis research
Colorado State University is a key partner in 2 multimillion-dollar projects aimed at producing new regenerative therapies for patients struggling with osteoarthritis, a degenerative joint disease that impacts millions of patients a year.
CSU Strata: CSU researchers use gene therapy to target osteoarthritis
Researchers at Colorado State University are working to improve the day-to-day lives of people and animals suffering from osteoarthritis. Osteoarthritis is a degenerative joint condition that causes pain, swelling, and stiffness, affecting a person’s ability to move freely. Laurie Goodrich, professor of orthopedics in the CSU Department of Clinical Sciences, and PhD candidate Jaiden Oropallo, are working to develop new treatment options for osteoarthritis through gene therapy—the reprogramming of cells—in companion animals.
CSU partners on up to $47 million federal award aimed at regrowing replacement joints to treat osteoarthritis
Two CSU research laboratories from the Translational Medicine Institute (TMI) will provide preclinical support for a $47 million award from ARPA-H to engineer and commercialize “live” replacement joints for osteoarthritis.